IOL CHEMICALS & PHARM. | PHAARMASIA | IOL CHEMICALS & PHARM./ PHAARMASIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | -27.7 | - | View Chart |
P/BV | x | 1.5 | 2.8 | 54.0% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. PHAARMASIA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
PHAARMASIA Mar-23 |
IOL CHEMICALS & PHARM./ PHAARMASIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 34 | 1,562.4% | |
Low | Rs | 272 | 20 | 1,347.5% | |
Sales per share (Unadj.) | Rs | 377.6 | 40.2 | 938.3% | |
Earnings per share (Unadj.) | Rs | 23.7 | -1.8 | -1,285.7% | |
Cash flow per share (Unadj.) | Rs | 31.6 | -1.3 | -2,397.9% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 15.8 | 1,622.6% | |
Shares outstanding (eoy) | m | 58.71 | 6.83 | 859.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.7 | 158.1% | |
Avg P/E ratio | x | 17.1 | -14.8 | -115.4% | |
P/CF ratio (eoy) | x | 12.8 | -20.7 | -61.9% | |
Price / Book Value ratio | x | 1.6 | 1.7 | 91.4% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 186 | 12,751.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 14 | 11,929.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 275 | 8,065.2% | |
Other income | Rs m | 256 | 5 | 4,963.2% | |
Total revenues | Rs m | 22,427 | 280 | 8,008.0% | |
Gross profit | Rs m | 2,257 | -15 | -14,615.9% | |
Depreciation | Rs m | 462 | 4 | 12,822.2% | |
Interest | Rs m | 165 | 0 | 36,600.0% | |
Profit before tax | Rs m | 1,887 | -14 | -13,173.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | -2 | -28,618.5% | |
Profit after tax | Rs m | 1,391 | -13 | -11,051.6% | |
Gross profit margin | % | 10.2 | -5.6 | -181.3% | |
Effective tax rate | % | 26.2 | 12.1 | 217.5% | |
Net profit margin | % | 6.3 | -4.6 | -137.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 150 | 6,425.9% | |
Current liabilities | Rs m | 5,025 | 173 | 2,907.3% | |
Net working cap to sales | % | 20.9 | -8.2 | -256.8% | |
Current ratio | x | 1.9 | 0.9 | 221.0% | |
Inventory Days | Days | 43 | 7 | 607.1% | |
Debtors Days | Days | 8 | 997 | 0.8% | |
Net fixed assets | Rs m | 11,017 | 133 | 8,268.8% | |
Share capital | Rs m | 587 | 68 | 860.0% | |
"Free" reserves | Rs m | 14,490 | 40 | 36,379.9% | |
Net worth | Rs m | 15,077 | 108 | 13,947.5% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 284 | 7,291.5% | |
Interest coverage | x | 12.5 | -30.8 | -40.4% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 1.0 | 110.6% | |
Return on assets | % | 7.5 | -4.3 | -175.7% | |
Return on equity | % | 9.2 | -11.6 | -79.2% | |
Return on capital | % | 13.6 | -12.8 | -106.0% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 7 | 18,810.8% | |
From Investments | Rs m | -1,200 | NA | 1,000,000.0% | |
From Financial Activity | Rs m | -41 | -2 | 2,521.5% | |
Net Cashflow | Rs m | -18 | 5 | -387.4% |
Indian Promoters | % | 48.2 | 73.5 | 65.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.1 | 2,833.3% | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 26.5 | 195.6% | |
Shareholders | 130,003 | 20,682 | 628.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | PHAARMASIA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.99% | 9.98% | -0.52% |
1-Month | -4.32% | 56.48% | 2.07% |
1-Year | -3.90% | 72.43% | 49.70% |
3-Year CAGR | -11.95% | 18.39% | 14.18% |
5-Year CAGR | 15.40% | 18.97% | 19.17% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the PHAARMASIA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of PHAARMASIA the stake stands at 73.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of PHAARMASIA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
PHAARMASIA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of PHAARMASIA.
For a sector overview, read our pharmaceuticals sector report.
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.